Table 3.
Characteristics | Included (n = 182) | Included, %/median (IQR) | Excluded (n = 820) | Excluded, %/median (IQR) | |
---|---|---|---|---|---|
Gender | Male | 74 | 41 | 345 | 42 |
Female | 108 | 59 | 475 | 58 | |
Age at onset, years | 5–10 | 101 | 55 | 306 | 37 |
≥11 | 40 | 22 | 250 | 31 | |
Missing or <5 | 41 | 22 | 264 | 32 | |
Overall | 153 | 8.8 (6.6–11.1) | 602 | 10.2 (7–12.5) | |
JIA subtype | Systemic arthritis | 8 | 4 | 55 | 7 |
Persistent oligoarthritis | 75 | 41 | 292 | 36 | |
Extended oligoarthritis | 7 | 4 | 17 | 2 | |
Polyarthritis (RF−) | 27 | 15 | 131 | 16 | |
Polyarthritis (RF+) | 6 | 3 | 31 | 4 | |
ERA | 12 | 7 | 58 | 7 | |
Psoriatic arthritis | 15 | 8 | 68 | 8 | |
Unclassifiable JIA | 32 | 18 | 110 | 13 | |
Other inflammatory arthritis | 0 | 0 | 30 | 4 | |
ILAR missing | 0 | 0% | 26 | 3% | |
Core outcome variables | CHAQ | 164 | 0.625 (0.125–1.375) | 451 | 0.625 (0.125–1.25) |
Parent VAS | 164 | 16.5 (4–49) | 409 | 24 (5–50) | |
Physician VAS | 144 | 30 (16–53) | 502 | 28 (15–49) | |
Active joint count | 165 | 2 (1–6) | 611 | 2 (1–5) | |
Limited joint count | 165 | 1 (1–4) | 611 | 1 (0–4) | |
ESR | 101 | 19 (7–44) | 464 | 20 (7–50) |